Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.85 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)632.98K
Market Cap
$72.68M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.04
Next Earnings
Aug 06, 2025EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding35,978,924
10 Day Avg. Volume398,455
30 Day Avg. Volume632,983
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8.70Price Target Upside339.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMyomo recently reported Q1 results with revenue exceeding estimates, showing strong performance.
Operational OutlookLead generation headwinds subside, which is a positive sign for the company's operational outlook.
Bears Say
Patient PipelineThe change to Meta’s guidelines to the sharing of personal health information on Facebook resulted in fewer potential patients added to the pipeline during the first quarter.
Revenue GuidanceManagement introduced lower-than-expected 2Q25 revenue guidance of $9.0M–$9.5M, below prior at-consensus estimate.
Myomo News
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $1.84 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $72.68M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Aug 06, 2025 which is in 6 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on May 07, 2025. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.076 by -$0.004.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.11.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 35,978,924 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.076. Following the earnings report the stock price went down -30.579%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
Myomo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.70 (339.39% Upside)
$8.70 (339.39% Upside)
Blogger Sentiment
Neutral
MYO Sentiment 50%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $390.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.9%
Last 30 Days ▲ 10.5%
Last 30 Days ▲ 10.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.87%
12-Months-Change
Fundamentals
Return on Equity
-35.68%
Trailing 12-Months
Asset Growth
147.37%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc. (MYO) is a medical robotics company that specializes in the development and commercialization of powered orthotic devices to improve mobility for individuals with neurological disorders and upper-limb paralysis. The company's flagship product, the MyoPro, is a lightweight, wearable robotic device designed to restore the ability to perform activities of daily living to individuals who have suffered strokes, brachial plexus injuries, or other neuromuscular disorders. Myomo operates primarily in the healthcare sector, focusing on rehabilitation and assistive technology.
MYO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and promising developments in the O&P channel and international markets. However, the company faced challenges in lead generation due to changes in Meta's policies and high denial rates from Medicare Advantage plans, which impacted the authorization rate and operating expenses. Despite these challenges, the company maintained its full-year guidance and showed confidence in overcoming these hurdles.Read More>MYO Stock 12 Month Forecast
Average Price Target
$8.70
▲(339.39%Upside)
Technical Analysis
Ownership Overview
17.15% Insiders
5.64% Mutual Funds
0.92% Other Institutional Investors
69.58% Public Companies and
Individual Investors